1. Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitors
- Author
-
Denis Riendeau, Jie Lan, Wanda Cromlish, Christoph Binkert, Patrick Hess, Anick Auger, Walter Fischli, Susana Liu, Beat Steiner, M. David Percival, René St-Jacques, Jennifer Harris, and Sylvie Toulmond
- Subjects
Mean arterial pressure ,medicine.medical_specialty ,Medicine (General) ,Rat model ,Angiotensinogen ,Blood Pressure ,Human renin ,Rats, Sprague-Dawley ,Endocrinology ,R5-920 ,Enalapril ,Fumarates ,Heart Rate ,Internal medicine ,Renin–angiotensin system ,Heart rate ,Renin ,Internal Medicine ,medicine ,Animals ,Humans ,Tissue Distribution ,RNA, Messenger ,Messenger RNA ,business.industry ,Amides ,Macaca mulatta ,Rats ,Disease Models, Animal ,Blood pressure ,Gene Expression Regulation ,Hypertension ,Female ,Rats, Transgenic ,business ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug ,circulatory and respiratory physiology - Abstract
Introduction: The hypertensive double-transgenic (dTG) rat strain, expressing human renin and angiotensinogen, develops severe hypertension and organ damage and 50% of individuals die by 7 weeks of age. Here, we characterise a variation of this model in which animals present stable hypertension.Materials and methods: The effect of renin—angiotensin system blockers on blood pressure was determined with adult dTG rats treated with enalapril from 3 to 12 weeks of age. Tissue expression levels of renin and angiotensinogen were determined in dTG rats and rhesus monkeys by quantitative PCR.Results: Upon withdrawal from enalapril, mean arterial pressure (MAP) rose to 160—180 mmHg, with 95% of the female dTG rats surviving for 6 to 12 months, In Sprague-Dawley (SD) rats and rhesus monkeys, renin mRNA was absent or weakly expressed in most tissues, except for the kidneys and adrenals. In dTG rats, human renin expression was high in many additional tissues. The expression of human angiotensinogen in dTG rats followed a similar tissue pattern to SD and rhesus monkey angiotensinogen. Oral dosing of aliskiren, enalapril or losartan provided a similar maximal reduction in MAP and duration of efficacy in telemetrised dTG rats.Conclusions: Enalapril-pretreated dTG rats are suitable for long-term MAP monitoring and sequential evaluation of human renin inhibitors.
- Published
- 2011